Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse articles > Author index
Search
Tae-Jin Lee 1 Article
Prevalence and healthcare utilization of herpes zoster and postherpetic neuralgia in South Korea: disparity among patients with different immune statuses
Chelim Cheong, Tae-Jin Lee
Epidemiol Health. 2014;36:e2014012.   Published online August 14, 2014
DOI: https://doi.org/10.4178/epih/e2014012
  • 14,999 View
  • 144 Download
  • 12 Citations
AbstractAbstract PDF
Abstract
OBJECTIVES
Despite the clinical and epidemiological importance of herpes zoster (HZ) and postherpetic neuralgia (PHN), their disease and economic burden related to immune status has not been studied in South Korea. Our aim was to calculate the prevalence and rate of healthcare utilization related to HZ and PHN among Korean patients stratified by immune status.
METHODS
This retrospective study used the Health Insurance Review and Assessment Service National Patients Sample (HIRA K-NPS) database, which includes all medical claims from January to December 2009 on a representative sample of the Korean population. HZ and PHN patients aged ≥ 50 years were categorized into three groups by immune status: severely immunocompromised group, moderately compromised group, and non-compromised group. The prevalence, disease-related healthcare utilization, and medical costs were compared across the three groups.
RESULTS
We estimated that there were 312,136 HZ patients and 48,461 PHN patients ≥ 50 years in South Korea. The prevalence of HZ and PHN was 18.54 and 2.88 per 1,000 persons, respectively, and increased with deteriorating immune status. The number of outpatient visits and hospitalization rate among HZ patients were highest in the severely immunocompromised group (4.38% and 7.52%, respectively) and lowest in the non-compromised group (3.82% and 4.08%, respectively). The average medical cost per patient in the severe group was the highest (240 US dollars) and that of the non-compromised group was the lowest (161 US dollars). No parameters were significantly different among patients with PHN by immunity.
CONCLUSIONS
HZ patients with severe immunodeficiency had a higher prevalence of HZ, more outpatient visits and hospitalizations, longer hospitalizations, and higher medical costs than their counterparts did. Efforts should be made to reduce the HZ-related burden of severely immunocompromised patients.
Summary
Korean summary
Key Message

Citations

Citations to this article as recorded by  
  • Thinking Outside the Tooth
    Akihiro Ando, Phuu P. Han, Seena Patel
    Dental Clinics of North America.2022; 66(2): 229.     CrossRef
  • Longdan X iegan formula as adjuvant therapy for acute herpes zoster: A meta‐analysis of randomized controlled trials
    Luxia Zhang, Aijun Duan, Yanfeng Li, Jing Feng
    Dermatologic Therapy.2022;[Epub]     CrossRef
  • Chondromalacia patella increases the risk of herpes zoster: a population-based study
    Chia-Hung Chen, Yung-Chi Cheng, Hsin-Yi Yang, Ching-Fang Tsai, Chao-Yu Hsu, Der-Shin Ke, Wen-Che Hsieh
    BMC Musculoskeletal Disorders.2022;[Epub]     CrossRef
  • Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016
    Sarah A Buchan, Nick Daneman, Jun Wang, Gary Garber, Anne E Wormsbecker, Sarah E Wilson, Shelley L Deeks
    Clinical Infectious Diseases.2020; 71(1): 22.     CrossRef
  • Asthma increases the risk of herpes zoster: a nested case–control study using a national sample cohort
    So Young Kim, Dong Jun Oh, Hyo Geun Choi
    Allergy, Asthma & Clinical Immunology.2020;[Epub]     CrossRef
  • Measuring herpes zoster disease burden in São Paulo, Brazil: a clinico-epidemiological single-center study
    João Toniolo-Neto, Eliofotisti Psaradellis, Angela Karellis, Emmanouil Rampakakis, Talita Y. Rockett, John S. Sampalis, Kelly D. Johnson, Homero A. Monsanto, Camilo J. Acosta
    Clinics.2018; 73: e243.     CrossRef
  • Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific
    Liang-Kung Chen, Hidenori Arai, Liang-Yu Chen, Ming-Yueh Chou, Samsuridjal Djauzi, Birong Dong, Taro Kojima, Ki Tae Kwon, Hoe Nam Leong, Edward M. F. Leung, Chih-Kuang Liang, Xiaohong Liu, Dilip Mathai, Jiun Yit Pan, Li-Ning Peng, Eduardo Rommel S. Poblet
    BMC Infectious Diseases.2017;[Epub]     CrossRef
  • Incidence of herpes zoster amongst adults varies by severity of immunosuppression
    Carsten Schröder, Dirk Enders, Tania Schink, Oliver Riedel
    Journal of Infection.2017; 75(3): 207.     CrossRef
  • Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States
    Juliana L. Meyers, Shweta Madhwani, Debora Rausch, Sean D. Candrilli, Girishanthy Krishnarajah, Songkai Yan
    Human Vaccines & Immunotherapeutics.2017; 13(8): 1861.     CrossRef
  • Association between Treatment with Biologic Agents and the Incidence of Herpes Zoster in Rheumatoid Arthritis
    Doo-Ho Lim, Yong-Gil Kim
    Journal of Rheumatic Diseases.2017; 24(5): 251.     CrossRef
  • The Epidemiology of Myasthenia Gravis in Korea
    Hyung Seok Lee, Hye Sun Lee, Ha Young Shin, Young-Chul Choi, Seung Min Kim
    Yonsei Medical Journal.2016; 57(2): 419.     CrossRef
  • Higher prevalence of dementia in patients with schizophrenia: A nationwide population-based study
    Hyemin Ku, Eui-Kyung Lee, Kyoung-Uk Lee, Min-Young Lee, Jin-Won Kwon
    Asia-Pacific Psychiatry.2016; 8(2): 145.     CrossRef

Epidemiol Health : Epidemiology and Health